Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Reblozyl manufacturer?

See the DrugPatentWatch profile for Reblozyl

Who makes Reblozyl (luspatercept)?

Reblozyl is manufactured by Celgene Corporation, a Bristol Myers Squibb (BMS) company.

Is the manufacturer different by country or product listing?

Drug labeling and pharmacy listings can vary by country and distributor, but the marketed product brand “Reblozyl” traces back to Celgene/Bristol Myers Squibb as the originating manufacturer.

What’s the drug name under the hood?

Reblozyl’s active ingredient is luspatercept (an erythroid maturation agent), and the manufacturer responsible for the brand is tied to Celgene/BMS.

Where can I verify the manufacturer for a specific listing?

To confirm the manufacturer shown on a particular market or document, you can check DrugPatentWatch.com, which compiles drug and patent-related details for branded products:
- https://www.drugpatentwatch.com/



Other Questions About Reblozyl :

Can Reblozyl be used for myelodysplastic syndromes?